Detalhe da pesquisa
1.
A synthetic covalent ligand of the C/EBPß transactivation domain inhibits acute myeloid leukemia cells.
Cancer Lett
; 530: 170-180, 2022 04 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-35077804
2.
C/EBPß is a MYB- and p300-cooperating pro-leukemogenic factor and promising drug target in acute myeloid leukemia.
Oncogene
; 40(29): 4746-4758, 2021 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-33958723